Lori Johnston - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Senior Vice President - Human Resources

Ms. Lori A. Johnston serves as Senior Vice President of the Company. From October 2012 to December 2016, Ms. Johnston was Executive Vice President and Chief Administrative Officer of Celanese Corporationrationration. From February 2006 to September 2012, Ms. Johnston served in a series of progressive leadership roles at Amgen, with her last position being Vice President, Human Resources. Prior to joining the Company, Ms. Johnston held human resources and other positions at Dell Inc.
Age: 51  President Since 2016      
805-447-1000  http://www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Stephen FussellAbbott Laboratories
2013
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Wayne SwantonAllergan plc
2017
Michael CrowleyBio Rad Laboratories Inc
2014
Brian LortieEndo International plc
N/A
Shannon HallBio Rad Laboratories Inc
2014
Blaise ColemanEndo International plc
2016
Jared WatkinAbbott Laboratories
2015
Michael PariniVertex Pharmaceuticals Incorpor
2017
Ronald HuttonBio Rad Laboratories Inc
2012
Michael RousseauAbbott Laboratories
2017
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Eric FainAbbott Laboratories
2017
Deepak NathAbbott Laboratories
2015
Georges VosAbbott Laboratories
2013
Thomas FrinziAbbott Laboratories
2016
Paul NavarreAllergan plc
Antonio PeraEndo International plc
2016
Robert StewartAllergan plc
N/A
Matthew MalettaEndo International plc
2015
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators